@phdthesis{Chamas2015,
  author    = {Alexandre Chamas},
  title     = {Development of novel Surface Plasmon Resonance-based biosensors with purified recombinant human HER-2 and progesterone receptor produced in two different yeast species},
  journal    = {Entwicklung innovativen Surface Plasmon Resonnanz-basierter Biosensoren mit gereinigten rekombinanten humanen HER-2 und Progesteron Rezeptor in zwei verschiedenen Hefearten hergestellt},
  url       = {https://nbn-resolving.org/urn:nbn:de:gbv:9-002273-5},
  year      = {2015},
  abstract  = {The following work is describing the development of two innovative biosensors for the detection of biologically relevant molecules in the field of ecology and medical diagnostics. Biosensors have the particularity to possess a biological partner which recognizes the target molecule and a physical detection method responsible for the transformation of this biological interaction into measurable information. In the present case, both biosensors are designed following the same strategy and use a recombinant produced human receptor as biological partner and the surface plasmon resonance (SPR) technique to transform the biological interaction in quantitative information. The progesterone biosensor is aimed to detect and quantify substances with affinity to the human progesterone receptor. The recent discoveries that some chemicals present in low quantities in the ecosystem called endocrine disrupting chemicals (EDCs) have a negative impact on the aquatic life fitness raised concerns about the effects of these same molecules to the human health. In order to assess the effects of these EDCs, the use of classical analytical detection methods like high performance liquid chromatography (HPLC) or gas chromatography (GC) is not sufficient as these techniques only quantify a defined molecule without giving information about its biological activity. By integrating a recombinant human progesterone receptor, the progesterone biosensor can determine the biological activity of an unknown molecule or of a mixture of molecules in a real sample. In this work, two different yeasts – one methylotrophic (Hansenula polymorpha) and one non-methylotrophic (Arxula adeninivorans) - were selected as host for the recombinant protein production and their performances were compared. Different purification strategies were assayed and the binding activity of the purified progesterone receptor was then confirmed by enzyme like receptor assay (ELRA) and SPR. This led to the design of a first version of the biosensor with the immobilization of a progesterone-BSA ligand to the surface of a SPR chip and the use of a progesterone receptor mixed with the target molecule as sample. This competitive assay format was successfully utilized with a commercial progesterone-BSA ligand as target molecule and the next step will be the adaptation of this biosensor for real samples measurements. The HER-2 biosensor was developed as an answer for one of the most critical issue in the field of breast cancer diagnostics. In approximately 30 \% of cancer cases, the transmembrane protein HER-2 can be found in large amount at the surface of the carcinoma cells and these cases are known to be particularly aggressive. Based on the amount of HER-2 protein at the surface of the cells, the pathologists established a scale with four levels to adapt the treatment to each patient. Although effective therapies have been developed to treat the HER-2 positive breast cancer, one of the major challenges remains the classification of breast sample in this scale as the only accepted determination methods are immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) which are only qualitative. In this work, a biosensor has been designed to quantify the amount of the HER-2 protein in a crude cell extract from a breast cancer tissue sample. To achieve this, the strategy is to utilize an antibody specifically targeted against the HER-2 protein and bound to a SPR chip. As the development of this biosensor necessitated the use of large amount of purified HER-2 protein, it was decided to produce recombinant full-length HER-2 in two different yeasts and to purify it by chromatography. This recombinant protein production required particular attention due to the membrane localization of HER-2. The structural integrity of the recombinant protein was confirmed by Western Blot and ELISA and different antibodies were bound to SPR chips in order to detect the HER-2 protein. After finding the conditions giving an optimal SPR signal, a protocol was developed to extract native HER-2 from breast tissue sample and the biosensor was assayed with this crude cell extract.},
  language  = {en}
}